Skip to main content
Premium Trial:

Request an Annual Quote

Kailos Expands Partnership With US DoD on Genetic Identification for Counter-Terrorism

NEW YORK (GenomeWeb) – Genetic testing firm Kailos Genetics announced today that it has expanded its existing partnership with the US Department of Defense's Combating Terrorism Technical Support Office (CTTSO).

Under the terms of the agreement, Kailos will continue developing a laboratory and software solution for analysis and identification of genetic material, for the purposes of counter-terrorism.

"Through enriching and deeply sequencing DNA samples, we can uncover information to positively impact the work being done by federal investigative agencies," Kailos CSO Troy Moore said in a statement.

The DoD established the CTTSO in 1999, with a mission to "identify and develop capabilities to combat terrorism and irregular adversaries and to deliver these capabilities to DoD components and interagency partners."

Kailos, based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama, said it reached several milestones set by the CTTSO to verify the credibility of its targeted genetic sequencing methods, including complete sequencing of hundreds of genetic samples, some of which had been genotyped by alternative methodologies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.